- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/48 - Hydrolases (3) acting on peptide bonds (3.4)
Patent holdings for IPC class A61K 38/48
Total number of patents in this class: 3879
10-year publication summary
361
|
350
|
395
|
402
|
351
|
392
|
338
|
332
|
279
|
23
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Allergan, Inc. | 2438 |
156 |
Talengen International Limited | 87 |
65 |
Ipsen Biopharm Limited | 268 |
64 |
MERZ PHARMA GmbH & CO. KGaA | 612 |
62 |
Baxter International Inc. | 2459 |
37 |
The Regents of the University of California | 19517 |
36 |
Curemark, LLC | 78 |
36 |
Revance Therapeutics, Inc. | 153 |
34 |
Bioverativ Therapeutics Inc. | 213 |
33 |
Takeda Pharmaceutical Company Limited | 2943 |
31 |
The Children's Hospital of Philadelphia | 752 |
31 |
Modernatx, Inc. | 1206 |
31 |
Translate bio, Inc. | 413 |
30 |
Baxter Healthcare S.A. | 1850 |
29 |
HANSA Biopharma AB | 70 |
29 |
Penland Foundation | 38 |
29 |
Omrix Biopharmaceuticals Ltd. | 155 |
28 |
Talengen Institute of Life Sciences Co., Ltd. | 28 |
25 |
Alexion Pharmaceuticals, Inc. | 622 |
24 |
Smith & Nephew, Inc. | 2681 |
24 |
Other owners | 3045 |